Diffuse Large B Cell Lymphoma: Five Factors For A Prognosis

Diffuse large B cell lymphoma prognosis is contingent upon several factors, and can be determined by using a well-established and reliably predictive model known as the Revised International Non-Hodgkin's Lymphoma Prognostic Index (IPI or R-IPI). In order for this to be applicable, the patient must have been diagnosed with DLBCL and be treated with Rituximab-based combination chemotherapy, namely R-CHOP.

The Index uses five factors for a prognosis, assigns a single point to each factor if true, then takes the sum total and uses it to determine a survival rate percentage.

Prognosis Factors

  • AGE: Patients over the age of 60 add one point.
  • SERUM LDH: If LDH (lactate dehydrogenase) levels are elevated, add one point.
  • PERFORMANCE STATUS: If the patient's performance status is determined to be between 2 and 4 add one point.
  • DISEASE STAGE: If the patient is diagnosed at stage III or stage IV, add one point.
  • EXTRANODAL INVOLVEMENT: If the patient's lymphoma involves more than one extranodal site (such as bone, liver, spleen, or bone marrow), add one point.

So a patient can have between 0 and 5 points. Here's what those totals mean for a prognosis:

0 points

  • Prognosis: Very good
  • Predicted 4-year progression-free survival: 94 percent
  • Overall survival: 94 percent

1-2 points

  • Prognosis: Good.
  • Predicted 4-year progression-free survival: 80 percent
  • Overall survival: 79 percent

3-5 points

  • Prognosis: Poor
  • Predicted 4-year progression-free survival:53 percent
  • Overall survival: 55 percent

Conclusion

This index has shown to be a reasonably predictive model in determining a prognosis; however, it will not hold true for every single diagnosed and treated patient.

Related Reading

Photo: Pexels

More Articles

More Articles

According to a study by Japanese researchers, the SMILE combination chemotherapy protocol is effective against extranodal natural killer/T-cell...

Patients treated with maintenance rituximab had three times longer progression-free survival. This is a summary of an article published in the...

When you consider that the adult human body has anywhere from 300 to 700 lymph nodes, the better question might not be where ARE they located, but...

This entry looks at a non-Hodgkin's lymphoma called true histiocytic lymphoma (THL), also referred to as diffuse histiocytic lymphoma, and...

Lymphomatous meningitis [LM], also known as leukemic meningitis, is an extremely serious peripheral cancer that attacks the tissue that covers the...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Intravascular lymphoma is a subtype of 'Lymphoma', an umbrella term that loosely refers to several dozen...

While the average lifespan for hamsters is only about 2.5 years, and they are therefore less prone to long-term illnesses, it is possible for a...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Lymphoma is a life-threatening disease, but is very treatable in most cases. The 5-year survival for patients diagnosed with non-Hodgkin's...

T cell lymphoma treatment options for these cancers are not especially effective and there is no absolute consensus about optimal treatments for...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Lymphomas can arise from most any lymphatic tissue (lymph nodes, spleen, thymus, mucosa associated lymphoid...